Advocacy & Action

Australia Publishes Outcome of Sunscreen Consultation

  Following a consultation, Australia’s Therapeutic Goods Administration (TGA) has outlined reforms to modernize sunscreen regulation. Key updates include strengthening SPF testing standards, establishing ingredient quality guidelines, revising Good Manufacturing […]

Read more

FDA Issues Final Guidance on Mandatory Cosmetic Recalls

  On October 22, 2026, the U.S. Food and Drug Administration (FDA) finalized its guidance document, Questions and Answers Regarding Mandatory Cosmetics Recalls: Guidance for Industry. MoCRA grants the FDA […]

Read more

Update to the Monograph Initiative

Updates to the Monograph Initiative

  The Natural and Non-prescription Health Products published monograph updates on October 30, 2026. The titles of the following monographs have been revised to ensure consistency with the terminology used […]

Read more

NNHPD Performance Standards

NNHPD Performance Standards

  PRODUCT APPLICATIONS:     Class I Applications:  Currently meeting service standards.     Class II Applications (meeting Workload Management eligibility      criteria):  There are approximately 1150 prioritized files […]

Read more

DSL Updated to Identify Low Concern Polymers

As reported in our February Regulatory Essentials, a Notice of intent to amend the Domestic Substances List, adding the letter “P” to the identifiers of 220 reduced regulatory requirement polymers […]

Read more